Method of treating viral hemorrhagic fever with activated protein C
AssigneeEli Lilly and Company
InventorsCharles Jack Fisher, Sau-Chi Betty Yan
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of treatment of viral hemorrhagic fever with activated protein C. The claimed invention provides a needed therapy for a serious and debilitating disorder while avoiding complications such as bleeding tendency, toxicity and general side effects of currently available anti-coagulant agents.
Claims8
A method of treating a patient suffering from viral hemorrhagic fever which comprises, administering to said patient a pharmaceutically effective amount of activated protein C.
A method of treating viral hemorrhagic fever in a patient in need thereof, which comprises administering to said patient a pharmaceutically effective amount of activated protein C such that an activated protein C plasma level of about 2 ng/ml to about 300 ng/ml is achieved.
Dependencies are inferred from the claim text.